Nanocarriers can be engineered to release drugs in a controlled manner. For instance, pH-sensitive nanoparticles can release their payload in response to the acidic environment of infected tissues. Additionally, magnetic nanoparticles can be guided to the infection site using external magnetic fields. These targeted approaches ensure that higher concentrations of the drug reach the affected areas, enhancing treatment outcomes.
